Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analyzing both DNA and RNA from tissue and blood using a streamlined four-step workflow.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback